+------------------------------------------------------------------------------+
Pfizer, Astra Deal May Have Failed on Tax, Soriot Says: CNBC 2014-11-28 06:42:47.933 GMT
By Morwenna Coniam Nov. 28 (Bloomberg) -- If AstraZeneca had agreed to deal at the time, it “probably” would have “fallen apart by now,” due to changes to U.S. tax inversion laws, according to AstraZeneca CEO Pascal Soriot, CNBC reports, citing an interview. * A deal would have “created enormous destruction and disruption” in the company: CNBC * “Can’t predict” what will happen with regards to a second bid: CNBC * NOTE: AstraZeneca rebuffed a $117b offer from Pfizer in May, saying the bid undervalued its drug pipeline * NOTE: Nov 18, AstraZeneca’s Soriot Asks for Patience as Pfizer Return Looms
For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>
To contact the reporter on this story: Morwenna Coniam in Hong Kong at +852-2977-6612 or mconiam@bloomberg.net To contact the editors responsible for this story: Clyde Eltzroth at +1-212-617-1879 or celtzroth1@bloomberg.net Colin Keatinge, Morwenna Coniam